Publications by authors named "Eleni Frangou"

24Publications

Update on the cellular and molecular aspects of lupus nephritis.

Clin Immunol 2020 Jul 25;216:108445. Epub 2020 Apr 25.

Rheumatology, Clinical Immunology and Allergy, University of Crete Medical School, Greece; Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology - Hellas (FORTH), Heraklion, Greece; University Hospital of Iraklio, Iraklio, Greece. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2020.108445DOI Listing
July 2020

An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment.

Autoimmun Rev 2019 Aug 8;18(8):751-760. Epub 2019 Jun 8.

Medical School, University of Cyprus, Nicosia, Cyprus; Autoimmunity and Inflammation Laboratory, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Medical School, National and Kapodistrian University of Athens, Athens, Greece; 4th Department of Medicine, "Attikon" University Hospital, Athens, Greece; Joint Rheumatology Program, National and Kapodistrian University of Athens Medical School, Athens, Greece. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2019.06.011DOI Listing
August 2019

Trial of exercise to prevent HypeRtension in young adults (TEPHRA) a randomized controlled trial: study protocol.

BMC Cardiovasc Disord 2018 11 6;18(1):208. Epub 2018 Nov 6.

Oxford Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK.

View Article

Download full-text PDF

Source
https://bmccardiovascdisord.biomedcentral.com/articles/10.11
Publisher Site
http://dx.doi.org/10.1186/s12872-018-0944-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220491PMC
November 2018

Challenges in implementing model-based phase I designs in a grant-funded clinical trials unit.

Trials 2017 Dec 28;18(1):620. Epub 2017 Dec 28.

CRUK MRC Oxford Institute for Radiation Oncology, Gray Laboratories, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13063-017-2389-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746014PMC
December 2017

Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate.

Autoimmun Rev 2018 Jan 3;17(1):11-18. Epub 2017 Nov 3.

Joint Rheumatology Program, 4th Department of Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens Medical School and Biomedical Research Foundation of the Athens Academy, Athens, Greece; Medical School, University of Cyprus, Nicosia, Cyprus. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2017.11.003DOI Listing
January 2018

Gene expression and regulation in systemic lupus erythematosus.

Eur J Clin Invest 2013 Oct 31;43(10):1084-96. Epub 2013 Jul 31.

Biomedical Research Foundation of the Academy of Athens, Medical School of National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/eci.12130DOI Listing
October 2013

Parvovirus 4 infection and clinical outcome in high-risk populations.

J Infect Dis 2012 Jun 5;205(12):1816-20. Epub 2012 Apr 5.

Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jis291DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357136PMC
June 2012